NGEN NervGen Pharma Corp.
$2.19▲ +1.16%
Healthcare
Other
After hours
$2.19▲ +0.00%
Sep 11, 7:30 PM ET
Volume 559.1K
Avg Volume (10D) 641.5K
Key Metrics & Fundamentals
Market Cap
$234.94M
P/E Ratio
–
Div Yield
–%
52W Range
1.58 - 6.30
% vs 50 MA
16.14%
% vs 200 MA
-35.15%
RSI-14
58.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.70
Free Cash Flow
-$5.73M
Gross Rev
$0
Gross Profit
$0
EBITDA
$5.02M
COGS
–
Operating Exp
$12.20M
Operating Income
-$12.20M
EBIT
-$12.20M
Pretax Income
-$29.22M
Net Income
-$29.22M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NGEN's money flow as a full page
Social Sentiment
Avg +0.75 · 4 posts
NewsDiscussionTradePublic offering of stock: NervGen Pharmaceuticals: $ngen and what should current holders do about it?
r/stocks · May 22, 2026
The post focuses on a public offering and asks about holding strategies, indicating potential positive sentiment regarding the company.
positive
+0.60
Thoughts on Nerven Pharma ($NGEN) ?
r/stocks · Jan 19, 2026
The comments highlight promising trial results and significant stock performance, indicating a bullish sentiment.
positive
+0.80
NewsDD$NGEN - Experimental Drug Shows Results
r/wallstreetbets · Oct 3, 2025
The user reports regaining full arm function and significant improvements, indicating extremely positive results for the company.
very_positive
+1.00
DDNewsTradeNGEN up 120% in the last month, trial results on June 3rd, don't sleep on this one
r/wallstreetbets · May 21, 2025
The post highlights a significant price increase and encourages investment, suggesting a positive sentiment toward the stock.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.
